ZINC 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)PYRIDAZINE-3-CARBOXYLATE
UNII 7J6242JL2A
Substance Identification & Data
This profile provides standardized clinical and technical data for Zinc 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7J6242JL2A.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2245111-19-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
2C19H18N7O4.Zn UMUQEYKVUKQYDI-UHFFFAOYSA-L Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Zinc 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.